The Tolerability of, and Adherence to, Dolutegravir With Co-formulated Tenofovir-emtricitabine for HIV Non-occupational Post-exposure Prophylaxis

Clinical trial NCT02211690 · COMPLETED

Trial details

NCT number: NCT02211690
Sponsor: Andrew Carr
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Human Immunodeficiency Virus

Start date: 2014-08-01
Primary completion: 2015-11-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.